Bioequivalence Study in Healthy Volunteers
Completed · Phase 1
Conditions studied: Healthy
In brief
Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.
Key facts
- Study ID
- NCT00387985
- Run by
- Bausch Health Americas, Inc.
- Starts
- 2006-08-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2019-11-25
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG).
Where it is running
- Study site — Willingboro, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.